Daniquidone

DB12804InvestigationalSmall molecule

Daniquidone has been used in trials studying the treatment of Neoplasms.

Chemical structure of Daniquidone
Formula / weight
C15H11N3O · 249.273 g/mol (avg)
Also known as
Batracylin
Code names
BAY H 2049 · NSC-320846

Resolves to

Compound
UNIIE780TX33D2CAS67199-66-0ChEMBLCHEMBL114283PubChem71750
Clinical / RWD
PharmGKBPA166119201
Structure
InChIKeySRIOCKJKFXAKHK-UHFFFAOYSA-NSMILESNC1=CC=C2N=C3N(CC2=C1)C(=O)C1=CC=CC=C31
Targets
Q02880TOP2BP11388TOP2AP11387TOP1

What you can answer from here — as of January 29, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Daniquidone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In